Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964986315> ?p ?o ?g. }
- W2964986315 endingPage "2747" @default.
- W2964986315 startingPage "2747" @default.
- W2964986315 abstract "The human carboxylesterase 1 (CES1), responsible for the biotransformation of many diverse therapeutic agents, may contribute to the occurrence of adverse drug reactions and therapeutic failure through drug interactions. The present study is designed to address the issue of potential drug interactions resulting from the inhibition of CES1. Based on an ensemble of 10 crystal structures complexed with different ligands and a set of 294 known CES1 ligands, we used docking (Autodock Vina) and machine learning methodologies (LDA, QDA and multilayer perceptron), considering the different energy terms from the scoring function to assess the best combination to enable the identification of CES1 inhibitors. The protocol was then applied on a library of 1114 FDA-approved drugs and eight drugs were selected for in vitro CES1 inhibition. An inhibition effect was observed for diltiazem (IC50 = 13.9 µM). Three others drugs (benztropine, iloprost and treprostinil), exhibited a weak CES1 inhibitory effects with IC50 values of 298.2 µM, 366.8 µM and 391.6 µM respectively. In conclusion, the binding site of CES1 is relatively flexible and can adapt its conformation to different types of ligands. Combining ensemble docking and machine learning approaches improves the prediction of CES1 inhibitors compared to a docking study using only one crystal structure." @default.
- W2964986315 created "2019-08-13" @default.
- W2964986315 creator A5000825231 @default.
- W2964986315 creator A5005294445 @default.
- W2964986315 creator A5011862057 @default.
- W2964986315 creator A5015299495 @default.
- W2964986315 creator A5025853224 @default.
- W2964986315 creator A5078174062 @default.
- W2964986315 date "2019-07-29" @default.
- W2964986315 modified "2023-10-01" @default.
- W2964986315 title "Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1" @default.
- W2964986315 cites W1663154925 @default.
- W2964986315 cites W1691930647 @default.
- W2964986315 cites W1871478581 @default.
- W2964986315 cites W1881444267 @default.
- W2964986315 cites W1964749595 @default.
- W2964986315 cites W1971008344 @default.
- W2964986315 cites W1977055725 @default.
- W2964986315 cites W1980066215 @default.
- W2964986315 cites W1984831910 @default.
- W2964986315 cites W1989855172 @default.
- W2964986315 cites W1994052145 @default.
- W2964986315 cites W1996861305 @default.
- W2964986315 cites W2003147329 @default.
- W2964986315 cites W2016376459 @default.
- W2964986315 cites W2018518196 @default.
- W2964986315 cites W2021377028 @default.
- W2964986315 cites W2026315288 @default.
- W2964986315 cites W2032798411 @default.
- W2964986315 cites W2034346077 @default.
- W2964986315 cites W2046915340 @default.
- W2964986315 cites W2053519915 @default.
- W2964986315 cites W2054650621 @default.
- W2964986315 cites W2060781702 @default.
- W2964986315 cites W2062884696 @default.
- W2964986315 cites W2081000338 @default.
- W2964986315 cites W2089286073 @default.
- W2964986315 cites W2096772371 @default.
- W2964986315 cites W2098804488 @default.
- W2964986315 cites W2100029387 @default.
- W2964986315 cites W2100925113 @default.
- W2964986315 cites W2101373870 @default.
- W2964986315 cites W2120170324 @default.
- W2964986315 cites W2121686955 @default.
- W2964986315 cites W2124904450 @default.
- W2964986315 cites W2128832687 @default.
- W2964986315 cites W2128931976 @default.
- W2964986315 cites W2130780134 @default.
- W2964986315 cites W2131257415 @default.
- W2964986315 cites W2132629607 @default.
- W2964986315 cites W2133367885 @default.
- W2964986315 cites W2134967712 @default.
- W2964986315 cites W2136123966 @default.
- W2964986315 cites W2147466472 @default.
- W2964986315 cites W2151241390 @default.
- W2964986315 cites W2155711100 @default.
- W2964986315 cites W2155842706 @default.
- W2964986315 cites W2161672948 @default.
- W2964986315 cites W2169678694 @default.
- W2964986315 cites W2171466942 @default.
- W2964986315 cites W2194466652 @default.
- W2964986315 cites W2274150920 @default.
- W2964986315 cites W2388080941 @default.
- W2964986315 cites W2416192302 @default.
- W2964986315 cites W2544136853 @default.
- W2964986315 cites W2558999090 @default.
- W2964986315 cites W2794774007 @default.
- W2964986315 cites W2795104011 @default.
- W2964986315 cites W2889197896 @default.
- W2964986315 cites W2899070097 @default.
- W2964986315 cites W2920795827 @default.
- W2964986315 cites W3022707578 @default.
- W2964986315 cites W3023828467 @default.
- W2964986315 cites W1828106358 @default.
- W2964986315 doi "https://doi.org/10.3390/molecules24152747" @default.
- W2964986315 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6696021" @default.
- W2964986315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31362390" @default.
- W2964986315 hasPublicationYear "2019" @default.
- W2964986315 type Work @default.
- W2964986315 sameAs 2964986315 @default.
- W2964986315 citedByCount "7" @default.
- W2964986315 countsByYear W29649863152019 @default.
- W2964986315 countsByYear W29649863152021 @default.
- W2964986315 countsByYear W29649863152022 @default.
- W2964986315 countsByYear W29649863152023 @default.
- W2964986315 crossrefType "journal-article" @default.
- W2964986315 hasAuthorship W2964986315A5000825231 @default.
- W2964986315 hasAuthorship W2964986315A5005294445 @default.
- W2964986315 hasAuthorship W2964986315A5011862057 @default.
- W2964986315 hasAuthorship W2964986315A5015299495 @default.
- W2964986315 hasAuthorship W2964986315A5025853224 @default.
- W2964986315 hasAuthorship W2964986315A5078174062 @default.
- W2964986315 hasBestOaLocation W29649863151 @default.
- W2964986315 hasConcept C103697762 @default.
- W2964986315 hasConcept C104317684 @default.
- W2964986315 hasConcept C119857082 @default.
- W2964986315 hasConcept C159110408 @default.
- W2964986315 hasConcept C185592680 @default.